Ticker Report CG Oncology, Inc. (NASDAQ:CGON - Get Free Report) Director Hong Fang Song sold 650,455 shares of the business's stock in a transaction that occurred on Thursday, August 29th. The shares were sold at...\n more…
Zolmax CG Oncology, Inc. (NASDAQ:CGON - Get Free Report) has received a consensus recommendation of "Buy" from the seven ratings firms that are currently covering the company, Marketbeat Ratings reports...\n more…
Ticker Report CG Oncology, Inc. (NASDAQ:CGON - Free Report) - Roth Capital issued their Q3 2024 EPS estimates for shares of CG Oncology in a research note issued on Tuesday, August 27th. Roth Capital analyst B...\n more…
Globe Newswire IRVINE, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...\n more…
Zolmax CG Oncology, Inc. (NASDAQ:CGON - Free Report) - Equities researchers at Roth Capital issued their Q3 2024 EPS estimates for CG Oncology in a research note issued on Tuesday, August 27th. Roth...\n more…
Ticker Report Shares of CG Oncology, Inc. (NASDAQ:CGON - Get Free Report) gapped up before the market opened on Wednesday . The stock had previously closed at $36.51, but opened at $37.41. CG Oncology shares last...\n more…